Advertisement

Author: PWeekly

ADA 2013: Training Fat to Be Good

The Particulars: The effects of exercise on those who do not lose weight have not been well defined, particularly in regard to body fat activity. Data Breakdown: Men who underwent 12 weeks of exercise bicycle training for a...

Read More

ADA 2013: Predicting Type 1 Diabetes

The Particulars: The ability to predict patients who are most likely to develop type 1 diabetes would allow for identification of the disease in its earliest stages of development, interventions to preserve beta cell function,...

Read More

ASE 2013

New research is being presented at ASE 2013, the annual scientific sessions of the American Society of Echocardiography, from June 29 – July 2 in Minneapolis.   Meeting Highlights Predicting CHF Readmissions Valve...

Read More

ADA 2013

New research is being presented at the American Diabetes Association’s 73rd Scientific Sessions from June 21-25 in Chicago. Meeting Highlights Predicting Type 1 Diabetes Training Fat to Be Good Wide-Ranging Benefits of Intensive...

Read More

FDA Approves Xgeva for Giant Cell Tumor of the Bone

The U.S. Food and Drug Administration today expanded the approved use of Xgeva (denosumab) to treat adults and some adolescents with giant cell tumor of the bone (GCTB), a rare and usually non-cancerous tumor. GCTB generally...

Read More

Standard-Dose Radiation Best for Stage III NSCLC

A phase III trial in patients with stage III non-small cell lung cancer (NSCLC) concludes that standard dose (SD) radiotherapy (60 Gy) is safer and more effective than high-dose (HD) radiotherapy (74 Gy), extending survival by...

Read More

ASCO 2013: Burnout Among Oncologists

The Particulars: Many studies have explored burnout among oncologists practicing in the United States, but most of the recent data was released in the early 2000s. Data are also lacking on personal and professional...

Read More

Advertisement

For latest news and updates
Email-id is invalid

Meeting Coverage